Executive Committee

The ITOG Executive Committee provides leadership and strategic guidance to advance thyroid cancer research, clinical innovation, and collaboration. Representing leading institutions and specialties across thyroid oncology, the Committee helps guide ITOG’s scientific direction, foster meaningful partnerships, and shape initiatives that drive progress in research and patient care.

Gregory W. Randolph
Gregory W. RandolphMD, FACS, FACE
Harvard Medical School
Mass Eye and Ear

President (2024-2027)

Laura Boucai, MD
Laura Boucai, MD 
Memorial Sloan Kettering
 

Secretary (2024-2027)

Francis Worden, MD
Francis Worden, MD 
University of Michigan
 

Protocol Committee Chair (2024-2027)

Alan Ho, MD, PhD
Alan Ho, MD, PhD 
Memorial Sloan Kettering

Protocol Committee Chair (2024-2027)

Dwight Vicks, III
Dwight Vicks, IIIITOG Co-Founder
Vicks Printing

Chief Financial Officer (2024-2027)

Patrick Fiorenza, PhD
Patrick Fiorenza, PhD 
International Thyroid Oncology Group

Chief Executive Officer